Bath & Body Works (NYSE:BBWI – Free Report) had its price objective hoisted by Deutsche Bank Aktiengesellschaft from $51.00 to $52.00 in a research note released on Tuesday morning,Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.
A number of other analysts have also weighed in on the stock. JPMorgan Chase & Co. increased their price objective on shares of Bath & Body Works from $35.00 to $39.00 and gave the stock a “neutral” rating in a research note on Tuesday. Robert W. Baird decreased their price objective on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a report on Thursday, August 29th. Piper Sandler raised their target price on Bath & Body Works from $35.00 to $36.00 and gave the stock a “neutral” rating in a report on Tuesday. Wells Fargo & Company boosted their price target on Bath & Body Works from $32.00 to $38.00 and gave the company an “equal weight” rating in a report on Tuesday. Finally, Evercore ISI dropped their price objective on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating on the stock in a research note on Wednesday, August 28th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $41.88.
View Our Latest Stock Report on Bath & Body Works
Bath & Body Works Stock Up 1.1 %
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.02. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. As a group, equities analysts anticipate that Bath & Body Works will post 3.24 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.20%. The ex-dividend date is Friday, November 22nd. Bath & Body Works’s dividend payout ratio is presently 19.51%.
Insider Buying and Selling at Bath & Body Works
In other news, CEO Gina Boswell bought 6,000 shares of Bath & Body Works stock in a transaction on Wednesday, October 9th. The stock was acquired at an average price of $29.64 per share, with a total value of $177,840.00. Following the completion of the acquisition, the chief executive officer now directly owns 242,987 shares of the company’s stock, valued at $7,202,134.68. The trade was a 2.53 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.27% of the company’s stock.
Institutional Trading of Bath & Body Works
A number of institutional investors have recently made changes to their positions in BBWI. Anomaly Capital Management LP acquired a new position in Bath & Body Works during the second quarter worth about $113,995,000. FMR LLC lifted its stake in Bath & Body Works by 17,496.5% in the 3rd quarter. FMR LLC now owns 2,516,127 shares of the company’s stock worth $80,315,000 after purchasing an additional 2,501,828 shares in the last quarter. KBC Group NV boosted its holdings in shares of Bath & Body Works by 9,023.5% during the 3rd quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock worth $54,322,000 after purchasing an additional 1,683,160 shares during the last quarter. Erste Asset Management GmbH acquired a new position in shares of Bath & Body Works during the 3rd quarter worth approximately $50,483,000. Finally, Lone Pine Capital LLC grew its position in shares of Bath & Body Works by 15.8% in the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock valued at $441,871,000 after purchasing an additional 1,547,399 shares in the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.
About Bath & Body Works
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Featured Articles
- Five stocks we like better than Bath & Body Works
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- The How And Why of Investing in Oil Stocks
- 3 Penny Stocks Ready to Break Out in 2025
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.